Stryker completes acquisition of K2M
Kalamazoo, Michigan, Nov. 09, 2018 (GLOBE NEWSWIRE) — Stryker (NYSE:SYK) has completed the previously announced acquisition of K2M Group Holdings, […]
Celldex Presents Promising Interim Data from Phase 1 Study of Differentiated CD40 Agonist CDX-1140 at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
–Well tolerated; dose dependent biological effects consistent with CD40-mediated immune cell activity––Program development expanded based on results observed to date– […]
Achaogen Announces Presentations at Two Investor Healthcare Conferences in November
SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) — Achaogen, Inc. (NASDAQ: AKAO), a biopharmaceutical company discovering, developing and […]
REPEAT – Wayland Group Announces Definitive Agreement for Italian Joint Venture
TORONTO, Nov. 09, 2018 (GLOBE NEWSWIRE) — Wayland Group (CSE:WAYL) (FRANKFURT: 75M) (OTCQB:MRRCF) (“Wayland” or the “Company”) is pleased to […]
NewLink Genetics Presents Phase 1 Data Supporting Significantly Higher Exposure with Indoximod Prodrug, NLG802, and Biomarker Data from Two Phase 2 Trials Illustrating Indoximod’s Impact on the Tumor Microenvironment at SITC 2018
AMES, Iowa, Nov. 09, 2018 (GLOBE NEWSWIRE) — NewLink Genetics Corporation (NASDAQ:NLNK) announced that data from three separate trials are […]
LGI Homes, Inc. Announces $50 Million Stock Repurchase Program
THE WOODLANDS, Texas, Nov. 09, 2018 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) today announced that its Board of Directors […]
Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
— Presented Updated Data from Phase 2 Basket Studies in Bardet-Biedl Syndrome (BBS) and Alström Syndrome at the 57th Annual […]
Nuance Announces Corporate Governance Enhancement by Adopting Provision for Shareholders to Call Special Meeting
BURLINGTON, Mass., Nov. 09, 2018 (GLOBE NEWSWIRE) — Nuance Communications, Inc. (NASDAQ: NUAN) today announced that its Board of Directors […]
Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
– Management Hosting Webcast of Key Opinion Leader Discussion Today at 6:00 p.m. ET – CAMBRIDGE, Mass., Nov. 09, 2018 […]
Cue Biopharma Presents Foundational Data on Immuno-STAT Platform and CUE-101 at the Society for Immunotherapy of Cancer’s (SITC) 33rd Annual Meeting
CUE-101 Demonstrates Selective Binding and Preferential Activation/Expansion of Antigen-specific T Cells, Inhibition of Tumor Growth as Monotherapy and in Combination […]
